GB201617622D0 - Means and methods to treat inflammation - Google Patents

Means and methods to treat inflammation

Info

Publication number
GB201617622D0
GB201617622D0 GBGB1617622.4A GB201617622A GB201617622D0 GB 201617622 D0 GB201617622 D0 GB 201617622D0 GB 201617622 A GB201617622 A GB 201617622A GB 201617622 D0 GB201617622 D0 GB 201617622D0
Authority
GB
United Kingdom
Prior art keywords
methods
treat inflammation
inflammation
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1617622.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIB VZW and Universiteit Gent
Original Assignee
VIB VZW and Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIB VZW and Universiteit Gent filed Critical VIB VZW and Universiteit Gent
Priority to GBGB1617622.4A priority Critical patent/GB201617622D0/en
Publication of GB201617622D0 publication Critical patent/GB201617622D0/en
Priority to PCT/EP2017/076427 priority patent/WO2018073216A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
GBGB1617622.4A 2016-10-18 2016-10-18 Means and methods to treat inflammation Ceased GB201617622D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1617622.4A GB201617622D0 (en) 2016-10-18 2016-10-18 Means and methods to treat inflammation
PCT/EP2017/076427 WO2018073216A1 (en) 2016-10-18 2017-10-17 Means and methods to treat inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617622.4A GB201617622D0 (en) 2016-10-18 2016-10-18 Means and methods to treat inflammation

Publications (1)

Publication Number Publication Date
GB201617622D0 true GB201617622D0 (en) 2016-11-30

Family

ID=57680868

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1617622.4A Ceased GB201617622D0 (en) 2016-10-18 2016-10-18 Means and methods to treat inflammation

Country Status (2)

Country Link
GB (1) GB201617622D0 (en)
WO (1) WO2018073216A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7249961B2 (en) 2017-06-02 2023-03-31 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Polypeptides that bind ADAMTS5, MMP13 and aggrecan
WO2018220235A1 (en) * 2017-06-02 2018-12-06 Merck Patent Gmbh Mmp13 binding immunoglobulins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089843A1 (en) * 2001-03-13 2002-11-14 Millenium Pharmaceuticals, Inc. Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function
US20060002935A1 (en) * 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US9028822B2 (en) * 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
ES2368764T3 (en) * 2007-03-19 2011-11-22 Universität Stuttgart SELECTIVE ANTAGONISTS OF huTNFR1.
KR20100018040A (en) * 2007-06-06 2010-02-16 도만티스 리미티드 Methods for selecting protease resistant polypeptides
GB201018602D0 (en) * 2010-11-04 2010-12-22 Vib Vzw MMP8 inactivating antigen binding proteins
WO2012122464A1 (en) * 2011-03-10 2012-09-13 New York University Methods and compositions for modulating tnf/tnfr signaling

Also Published As

Publication number Publication date
WO2018073216A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
IL282570B (en) Methods and devices for treating pulmonary edema
IL255780A (en) Therapeutic combinations and methods for treating neoplasia
HK1243640A1 (en) Methods and compositions for treating ulcers
ZA201607540B (en) Compositions and methods to treating hemoglobinopathies
EP3151797A4 (en) Methods and devices for treating the skin
IL259570A (en) Combination treatments and uses and methods thereof
HK1244681A1 (en) Therapeutic combinations and methods for treating neoplasia
IL251759A0 (en) Compositions and methods for treating insomnia
IL246709A0 (en) Device and method to treat vaginal atrophy
PT3189074T (en) Compositions and methods for treating and preventing inflammation
PT3448516T (en) Phototherapy apparatuses and methods
EP2993160A4 (en) Water treatment device and water treatment method
HK1244711A1 (en) Treatment of hmgb1-mediated inflammation
ZA201701571B (en) Water treatment system and method
EP3093055A4 (en) Water treatment device and water treatment method
PL2993159T3 (en) Water treatment device and water treatment method
GB201617622D0 (en) Means and methods to treat inflammation
EP3119307A4 (en) Skin treatment devices and methods
IL255012A0 (en) Compositopns and methods for treating skin conditions
EP3159055A4 (en) Water treatment method and water treatment device
HK1244223A1 (en) Apoaequorin-containing compositions and methods of using same to treat neuronal inflammation
IL250244B (en) Preventing and treating inflammatory skin diseases
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
GB201419559D0 (en) Therapeutic compositions and methods
GB201409262D0 (en) Hair treatment compositions and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)